New “Peters on Diabetes” Videos

New “Peters on Diabetes” Videos​

Dr. Peters, Meg, Mary Rose and Mark all recently attended the American Diabetes Association Scientific Sessions in New Orleans to catch up on all of the updates on diabetes prevention, treatment and basic science. Dr. Peters provided a talk on the use of technology during the pandemic. She also provided a preview of two of the hot topics at the meeting for her Peters on Diabetes series and Mark covered other diabetes topics of interest at the meeting for Medscape.  Some are available now and others will be posted in the coming weeks. A free one-time registration is required to view the videos.


These videos are announced in our Twitter feed and Facebook page and will also be updated here. In addition to the recent ADA news there are also many other videos recorded by Dr. Peters since the past newsletter that you may want to view.​


Videos Previews to the 82nd ADA Scientific Sessions by Dr. Peters:



iLet System Simplifies Insulin Delivery for T1D 
Dr Anne Peters offers perspective on how the iLet automated insulin system works and can improve management for patients with type 1 diabetes.

Medscape Diabetes & Endocrinology, June 07, 2022 



Tirzepatide: 'Exciting' and Promising in Lowering A1c 
Tirzepatide is the newest player in the quest for lowering A1c in people with type 2 diabetes. Dr Anne Peters describes the novel agent -- what it can do for patients now and in the future.

Medscape Diabetes & Endocrinology, May 23, 2022 


Videos Reports from the 82nd ADA Scientific Sessions by Mark Harmel, MPH:



Providing Diabetes Care, Insulin, in Ukraine

With the crisis in Ukraine, it is imperative to ensure that insulin is available to those who need it. Dr Sylvia Kehlenbrink details the current response along with resources to provide aid. 

Perspectives, Apr 1, 2022

Managing Chronic Kidney Disease in Patients With Diabetes

Dr Sylvia Rosas discusses managing chronic kidney disease in patients with diabetes, as outlined in updated ADA 2022 Standards of Medical Care in Diabetes.

Perspectives, Jun 9, 2022

Insulin Cap Legislation: Addressing the Challenges of Access

Dr Irl Hirsch discusses the challenges of making insulin affordable and accessible and potential legislation that may help.

Perspectives, Jun 16, 2022


New Advances in Obesity Management, but Challenges Remain

Weight management is the driver of all chronic diseases, contends Dr Donna Ryan, who discusses her extensive experience in researching obesity and her optimism for new medication advances.

Perspectives, Jun 20, 2022

ADA-EASD: More Holistic Approach Needed for Hyperglycemia Management

Dr John Buse discusses the updated ADA-EASD consensus on managing hyperglycemia, including glycemic and weight management, cardiovascular risk reduction, and cardiorenal therapies or organ protection.

Perspectives, Jun 23, 2022

How Does Exercise Affect Type 1 Diabetes?

Dr Mike Riddell discusses recent research exploring the impact of exercise on glucose levels in patients with type 1 diabetes.

Perspectives, Jul 6, 2022

National Clinical Care Commission offers T2D Recommendations

William Herman, MD, MPH, discusses the National Clinical Care Commission recommendations on how to better prevent and treat type 2 diabetes. 

Perspectives, Jun 29, 2022


More to follow…


Earlier Videos of Interest to Patients by Dr. Peters:




Does COVID-19 Raise the Risk for Diabetes? 

Is COVID-19 responsible for new-onset diabetes? Or are COVID infections bringing to light previously undiagnosed cases? Dr Anne Peters reviews recent studies around COVID and diabetes.

Medscape Diabetes & Endocrinology, May 17, 2022 



Therapies 'Not Used Enough' in Patients With T2D and CVD Risk 

Dr Anne Peters discusses a paper demonstrating the low use of appropriate therapies in patients with type 2 diabetes and established cardiovascular risk.

Medscape Diabetes & Endocrinology, May 04, 2022 



What Is the Glycemic Risk Index and Why Do We Need It? 

Dr Anne Peters discusses the development of the glycemic risk index, a new continuous glucose monitoring measure.

Medscape Diabetes & Endocrinology, May 02, 2022 


'Worse Over Time': CDC Data on Diabetes and Obesity 

"No surprise that we've gotten worse over time," Dr. Anne Peters discusses recent data from the CDC on diabetes and obesity in the United States.

Medscape Diabetes & Endocrinology, March 02, 2022 


Omnipod 5 Automated Insulin Delivery System Approval 'Exciting' 

Dr Anne Peters discusses why she "can't wait to use" the newly approved Omnipod 5 Automated Insulin Delivery System in her patients.

Medscape Diabetes & Endocrinology, February 16, 2022 



Remission From Type 2 Diabetes Does Not Mean a Cure 

Lifestyle changes including healthy diet and increased exercise can lead to remission for patients with type 2 diabetes, allowing them to stop medication. But it is not a cure, reports Dr Anne Peters.

Medscape Diabetes & Endocrinology, January 11, 2022 


A Cure for Type 1 Diabetes? Not Yet, but We're Getting Closer 

Dr Anne Peters discusses results from recent studies suggesting that there may be a path to improving treatment for patients with type 1 diabetes.

Medscape Diabetes & Endocrinology, December 30, 2021 


Update: 2022 ADA Standards of Care 

Dr Anne Peters discusses updates contained in the ADA 2022 Standards of Medical Care in Diabetes.

Medscape Diabetes & Endocrinology, December 28, 2021 


L A T E S T   N E W S



There was big diabetes news even before the start of this year’s live and in-person gathering of the American Diabetes...




Just before the ADA meeting there was a big announcement of the FDA approval of a new Type 2 diabetes medication




The Freestyle Libre 3 is first of the smaller CGM sensors to earn FDA approved...                                 READ MORE...



Dr. Peters provided a preview of two of the hot topics at the ADA Scientific Sessions meeting for her Peters on...




All the data from the FEEL-T1D study is now collected, and our research team has been busy sifting through...